Drug Week

Hodgkin Disease - NOVP chemotherapy induces sperm aneuploidies

Human Papillomavirus - European patent granted for HspE7 and other human papillomavirus therapeutics

Huntington's Disease - Further progress reported on LAX-101 clinical development

Hypertension - New study sheds light on responses to diuretics

Infectious Disease - Ceftazidime use raises risk of resistant Klebsiella pneumoniae in Taiwan

Infectious Disease - Development cytomegalovirus vaccine announced

Infectious Disease Therapy - Phenothiazines, thioxanthenes block S. aureus drug efflux

Infectious Disease Therapy - RWJ-54428 effective against several forms of drug resistance

Inflammatory Diseases - Million-dollar grant awarded to identify inhibitors of chemokine receptors

Leukemia - Fludara receives European marketing approval as first-line B-CLL treatment

Leukemia - New HuMax-CD20 and HuMax-EGFr preclinical data presented

Malaria Therapy - Novel triterpenes derived from Caloncoba echinata

Malaria Therapy - Sulfadoxine-pyrimethamine-artesunate therapy planned for malaria in Peru

Mental Illness - Mania indication sought for Seroquel (quetiapine) in Europe

Mergers and Acquisitions - Biomedical firm intends to acquire selected assets of drug company

Multiple Myeloma - European regulatory approval sought for Velcade

Multiple Myeloma - FDA fast track status granted for Revimid in relapsed or refractory disease

Multiple Sclerosis - Interferon beta-1a formulation approved by FDA for early stage disease

Musculoskeletal Pain - Lower-dose Flexeril (cyclobenzaprine HCl) approved for muscle spasm

Neuropathic Pain - Data reported from Phase II trial on amitriptyline plus ketamine

Opportunistic Infection - Clinical trial of P. carinii pneumonia treatment completes enrollment

Oral Creatine - Repeated dosing causes clearance reduction, saturation of skeletal muscle pool

Osteoporosis - Mumie extract induces osteoblastic differentiation of mesenchymal stem cells

Osteoporosis - Preos maker provides clinical update

Parkinson Disease - The Michael J. Fox Foundation commits $2 million to study PD dyskinesia

Parkinson Disease - Worm model could yield new drugs

Pathogen Reduction - Company transfuses initial patients in both phase III trials for Inactine

Portal Hypertension - IND granted for phase I studies of NCX 1000

Prescription Fulfillment - Paragon's SI/BAKER joint venture awarded a $3.8 million contract

Prostate Cancer - Abbott Labs stops tests on key drug

Psoriasis - Raptiva agreement expanded to additional emerging markets in Asia

Pulmonary Medicine - Systemic thrombolytic therapy after recent abdominal aortic aneurysm repair

Renal Cell Carcinoma - Clinical trial of antisense drug expanded to major U.S. oncology centers

Sicor, Inc. - Final ANDA approval granted for Vinorelbine

Staphylococcus Aureus - Lack of synergy may be cause to avoid regimen to treat Staphylococcus aureus

Stem Cell Transplantation - Etoposide alters dendritic cell mobilization

Sunesis Pharmaceuticals, Inc. - Company announces breakthrough using extended tethering

Thrombosis - Extension of research funding granted on thrombin collaboration

Tonsillectomy - Nonsteroidal anti-inflammatory drugs suitable for pain relief

Tooth Whitener - Metagen Pharmaceuticals announces distribution agreement for Sparkling White

Tuberculosis Therapy - Mycobacterial glutamine synthetase inhibition effective

Ventilator-Associated Pneumonia - Phase II/III clinical study of iseganan HCl for VAP launch announced